NorthCoast Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

NorthCoast Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,352	Closed	-$227K	–	267
2019 Q3	$227K	Buy	+3,352	New	+$230K	0.02%	221
2019 Q2	–	Sell	-5,405	Closed	-$379K	–	286
2019 Q1	$379K	Buy	+5,405	New	+$401K	0.02%	216

NorthCoast Asset Management's GHDX Position: Q4 2019 in Review

NorthCoast Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,352 shares — an estimated $227K sold.

NorthCoast Asset Management first reported a position in GHDX in Q1 2019 and held it in 2 quarters. The position peaked at $379K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

NorthCoast Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
NorthCoast Asset Management sold 3,352 Genomic Health, Inc. shares in Q4 2019, an estimated $227K.
NorthCoast Asset Management first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 2 quarters.
NorthCoast Asset Management's Genomic Health, Inc. position peaked at $379K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on NorthCoast Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.